Gill Capital Partners’s Alpha Tau Medical Warrant DRTSW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-500
Closed -$1.48K – 276
2026
Q2
$1.48K Hold
500
– – ﹤0.01% 593
2026
Q1
$500 Buy
+500
New +$481 ﹤0.01% 634

Other funds holding DRTSW

Gill Capital Partners's DRTSW Position: Q3 2026 in Review

Gill Capital Partners sold out of Alpha Tau Medical Warrant (DRTSW) in Q3 2026, closing a stake of 500 shares — an estimated $1.48K sold.

Gill Capital Partners first reported a position in DRTSW in Q1 2026 and held it in 2 quarters. The position peaked at $1.48K in Q2 2026. 22 funds tracked by Wall St. Rank hold DRTSW as of Q3 2026.

  • Gill Capital Partners reported no remaining Alpha Tau Medical Warrant position as of Q3 2026 after selling out during the quarter.
  • Gill Capital Partners sold 500 Alpha Tau Medical Warrant shares in Q3 2026, an estimated $1.48K.
  • Gill Capital Partners first reported a position in Alpha Tau Medical Warrant in Q1 2026 and held it in 2 quarters.
  • Gill Capital Partners's Alpha Tau Medical Warrant position peaked at $1.48K in Q2 2026.
  • 22 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q3 2026.

Based on Gill Capital Partners's 13F filing for Q3 2026, filed 13 Oct 2026.